The OH AMR partnership aims to coordinate and align activities and funding between countries as well as with the Commission. It will also facilitate national coherence between different services and ministries with responsibility for the various aspects of antimicrobial resistance (AMR) (e.g. human health, agriculture, environment, industry, finances).

The main goal is to contribute to achieving the objectives of the European One Health Action Plan against AMR and the WHO Global Action Plan on AMR, by reducing the threat of AMR.

Expected impact

• Novel solutions to prevent and treat infectious diseases affected by AMR, improved diagnosis and control of the spread of resistant microorganisms, testing and validation of such solutions and facilitating their uptake or implementation.
• Decreased burden of infectious diseases, notably due to AMR pathogens and progress towards Sustainable Development Goal No. 3 ‘Ensure healthy lives and promote well-being for all at all ages’.
• Closed knowledge gaps on AMR, support provided to regulatory science and inform policymaking.

Timeline & key documents

• More information in the Draft outline of partnership proposal (February 2022)
• The CSA  Design OH AMR was launched in May 2022 and is leading the development of the One Health AMR Partnership, in collaboration with the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR).
• A first draft of the European Partnership OH AMR Strategic Research and Innovation Agenda was published in May 2023. The final text of the SRIA is foreseen to be submitted in 2024
• Launch of the first call and start of activities is foreseen for 2025   

Contact

Commission services: RTD-COMBATTING-DISEASES@ec.europa.eu

Contact JPIAMR: ohamr@vr.se